hygeia healthcare holdings co ltd - HYHHF

HYHHF

Close Chg Chg %
2.51 -0.83 -32.94%

Pre-Market

1.68

-0.83 (32.94%)

Volume: 100.00

Last Updated:

Jul 31, 2025, 9:47 AM EDT

Company Overview: hygeia healthcare holdings co ltd - HYHHF

HYHHF Key Data

Open

$1.68

Day Range

1.68 - 1.68

52 Week Range

N/A - N/A

Market Cap

$1.04B

Shares Outstanding

618.50M

Public Float

328.39M

Beta

-0.17

Rev. Per Employee

N/A

P/E Ratio

16.36

EPS

N/A

Yield

0.00%

Dividend

$0.02

EX-DIVIDEND DATE

Jun 30, 2023

SHORT INTEREST

N/A

AVERAGE VOLUME

N/A

 

HYHHF Performance

No Data Available

HYHHF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About hygeia healthcare holdings co ltd - HYHHF

Hygeia Healthcare Holdings Co., Ltd. operates as a biopharmaceutical company that focuses on the development of new clinical drugs. It operates through the following segments: Hospital Business, Radiotherapy Business, and Hospital Management Business. The Hospital Business segment operates through self-owned private for-profit hospitals which are variable interest entities owned by the group by undertaking group reorganization. The Radiotherapy Business segment offers licensing of radiotherapy equipment for use in the radiotherapy centres and provision of maintenance and technical support services in relation to radiotherapy equipment. The Hospital Management Business segment engages in provision of management services to private not-for-profit hospitals. The company was founded by Yiwen Zhu in 2009 and is headquartered in Shanghai, China.

HYHHF At a Glance

Hygeia Healthcare Holdings Co., Ltd.
Unit 1605/1606, Building 1
Shanghai, Shanghai 200120
Phone N/A Revenue 617.79M
Industry Pharmaceuticals: Major Net Income 83.13M
Sector Health Technology 2024 Sales Growth 7.368%
Fiscal Year-end 12 / 2025 Employees 8,169
View SEC Filings

HYHHF Valuation

P/E Current 16.358
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 13.886
Price to Sales Ratio 1.869
Price to Book Ratio 1.252
Price to Cash Flow Ratio 13.65
Enterprise Value to EBITDA 9.207
Enterprise Value to Sales 2.348
Total Debt to Enterprise Value 0.264

HYHHF Efficiency

Revenue/Employee 75,626.115
Income Per Employee 10,176.099
Receivables Turnover 5.034
Total Asset Turnover 0.41

HYHHF Liquidity

Current Ratio 1.018
Quick Ratio 0.865
Cash Ratio 0.361

HYHHF Profitability

Gross Margin 27.695
Operating Margin 18.865
Pretax Margin 16.887
Net Margin 13.456
Return on Assets 5.522
Return on Equity 9.287
Return on Total Capital 6.425
Return on Invested Capital 6.851

HYHHF Capital Structure

Total Debt to Total Equity 41.96
Total Debt to Total Capital 29.558
Total Debt to Total Assets 25.541
Long-Term Debt to Equity 33.914
Long-Term Debt to Total Capital 23.89
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Hygeia Healthcare Holdings Co Ltd - HYHHF

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
359.00M 474.57M 575.39M 617.79M
Sales Growth
+76.77% +32.19% +21.24% +7.37%
Cost of Goods Sold (COGS) incl D&A
246.98M 329.08M 403.61M 446.69M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
17.75M 22.75M 29.72M 41.01M
Depreciation
16.43M 21.10M 27.39M 38.24M
Amortization of Intangibles
1.32M 1.65M 2.32M 2.77M
COGS Growth
+80.91% +33.24% +22.65% +10.67%
Gross Income
112.02M 145.50M 171.78M 171.09M
Gross Income Growth
+68.28% +29.88% +18.06% -0.40%
Gross Profit Margin
+31.20% +30.66% +29.85% +27.69%
2021 2022 2023 2024 5-year trend
SG&A Expense
31.52M 37.96M 51.31M 48.80M
Research & Development
- - - -
-
Other SG&A
31.52M 37.96M 51.31M 48.80M
SGA Growth
+101.99% +20.45% +35.16% -4.90%
Other Operating Expense
1.74M 2.76M 4.24M 5.76M
Unusual Expense
(9.57M) (355.23K) (2.20M) 6.54M
EBIT after Unusual Expense
88.34M 105.13M 118.43M 110.00M
Non Operating Income/Expense
4.06M (4.42M) 8.50M 4.31M
Non-Operating Interest Income
334.14K 2.57M 1.43M 210.37K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
3.58M 5.18M 6.09M 9.98M
Interest Expense Growth
-48.71% +44.72% +17.63% +63.83%
Gross Interest Expense
3.58M 7.47M 10.53M 13.68M
Interest Capitalized
- 2.29M 4.43M 3.70M
Pretax Income
88.82M 95.54M 120.83M 104.33M
Pretax Income Growth
+142.69% +7.56% +26.48% -13.66%
Pretax Margin
+24.74% +20.13% +21.00% +16.89%
Income Tax
18.55M 23.97M 24.16M 21.19M
Income Tax - Current - Domestic
16.22M 24.22M 22.43M 23.27M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
2.33M (245.33K) 1.72M (2.08M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
70.27M 71.56M 96.68M 83.14M
Minority Interest Expense
1.82M 756.19K 285.11K 9.87K
Net Income
68.45M 70.81M 96.39M 83.13M
Net Income Growth
+177.78% +3.44% +36.13% -13.76%
Net Margin Growth
+19.07% +14.92% +16.75% +13.46%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
68.45M 70.81M 96.39M 83.13M
Preferred Dividends
- - - -
-
Net Income Available to Common
68.45M 70.81M 96.39M 83.13M
EPS (Basic)
0.1108 0.1148 0.1527 0.1322
EPS (Basic) Growth
+177.69% +3.61% +33.01% -13.43%
Basic Shares Outstanding
618.00M 616.82M 631.12M 628.99M
EPS (Diluted)
0.1108 0.1148 0.1527 0.1322
EPS (Diluted) Growth
+177.69% +3.61% +33.01% -13.43%
Diluted Shares Outstanding
618.00M 616.82M 631.12M 628.99M
EBITDA
96.51M 127.52M 145.95M 157.55M
EBITDA Growth
+57.41% +32.13% +14.45% +7.95%
EBITDA Margin
+26.88% +26.87% +25.36% +25.50%

Hygeia Healthcare Holdings Co Ltd in the News